Device Devices

Gore Septal Occluder

Payments companies reported to CMS as associated with Gore Septal Occluder. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$4,480associated payments (2023-2025)

44clinicians with associated payments

1company reporting

By year

2023 $1,701

2024 $2,728

2025 $50.60

Payments reported as associated with Gore Septal Occluder, per program year, as reported to CMS.

Who makes it

W. L. Gore & Associates, INC. $4,480 associated with Gore Septal Occluder (2023-2025)

Specialties most often involved

Cardiovascular Disease $1,656

Interventional Cardiology $1,059

Family $446

Nurse Practitioner $393

Thoracic Surgery (Cardiothoracic Vascular Surgery) $242

Physician Assistant $174

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Gore Septal Occluder

These are the largest totals companies reported as associated with Gore Septal Occluder. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Giorgio Medranda	Mineola, NY	Interventional Cardiology	$240.35
Sandeep Dhillon	Garden City, NY	Cardiovascular Disease	$240.35
Mitchell Lefland	Garden City, NY	Cardiovascular Disease	$240.35
Matthew Wright	Garden City, NY	Cardiovascular Disease	$240.35
Albert Schenone	Garden City, NY	Cardiovascular Disease	$240.35
Richard Schwartz	Garden City, NY	Interventional Cardiology	$240.35
Susan Sharma	Garden City, NY	Cardiovascular Disease	$240.35
Philip Ragno	Garden City, NY	Cardiovascular Disease	$240.35
Charles Schutt	Pensacola, FL	Neurology (Psychiatry & Neurology)	$130.86
Kevin Vitale	Pensacola, FL	Nurse Practitioner	$130.86

Prescribed Gore Septal Occluder?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.